Medical University Of South Carolina
Clinical trials sponsored by Medical University Of South Carolina, explained in plain language.
-
Could a shorter hospital stay stop bleeding just as well?
Disease control TerminatedThis study aimed to see if a 24-hour drug infusion works as well as the standard 72-hour infusion to prevent re-bleeding in patients with liver cirrhosis. It involved adults who had a procedure to stop bleeding from swollen veins in their esophagus. The goal was to determine if t…
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Vaccine trial halted early in fight against prostate cancer return
Disease control TerminatedThis study tested an experimental vaccine called PROSTVAC-V/F to see if it could stop prostate cancer from coming back after surgery in men at high risk of relapse. The trial was terminated early and enrolled only 33 participants before ending. Researchers aimed to measure how lo…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
Terminated trial sought new weapon against tough lung cancer
Disease control TerminatedThis study tested a combination of two drugs, tarloxotinib and sotorasib, for people with a specific type of advanced lung cancer (KRAS G12C mutation). It aimed to see if using both drugs together could control the cancer better than sotorasib alone, especially for patients whose…
Phase: PHASE1, PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Grape seed extract trial for prostate cancer halted early
Disease control TerminatedThis study tested whether a grape seed extract called OPC could reduce certain food-related substances (AGEs) in the blood of prostate cancer patients receiving hormone therapy. Researchers wanted to see if lowering AGE levels might help control cancer. The trial was terminated e…
Phase: PHASE2 • Sponsor: Medical University of South Carolina • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Could a Parkinson's pill rekindle lost interests?
Symptom relief TerminatedThis study aimed to see if an already-approved Parkinson's disease medication called istradefylline could help improve motivation and reduce apathy—a common symptom where people lose interest in activities. It planned to test this over 12 weeks in a small group of people with Par…
Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Mar 30, 2026 14:32 UTC
-
Sleep aid tested to help cancer survivors rest
Symptom relief TerminatedThis study tested whether the prescription sleep medication suvorexant could help breast cancer survivors who have trouble sleeping. A small group of survivors with significant insomnia were randomly assigned to receive either the drug or a placebo pill, along with basic sleep ad…
Phase: PHASE4 • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Mar 27, 2026 12:40 UTC